Review on pharmacokinetics and pharmacodynamics and the aging kidney
C Aymanns, F Keller, S Maus… - Clinical journal of the …, 2010 - journals.lww.com
In people who are aged> 65 years, pharmacokinetics are influenced more by the loss of
kidney function than by the aging process of any other organ. A GFR of 30 to 60 ml/min …
kidney function than by the aging process of any other organ. A GFR of 30 to 60 ml/min …
Incidence of immune-related adverse events with program death receptor-1-and program death receptor-1 ligand-directed therapies in genitourinary cancers
BL Maughan, E Bailey, DM Gill, N Agarwal - Frontiers in Oncology, 2017 - frontiersin.org
Program death receptor-1 (PD-1) and program death receptor-1 ligand (PD-L1) inhibitors
are increasingly being used in the clinic to treat a growing number of malignancies …
are increasingly being used in the clinic to treat a growing number of malignancies …
Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians
A Qaseem, LL Humphrey, DE Sweet… - Annals of internal …, 2012 - acpjournals.org
This article has been corrected. The original version (PDF) is appended to this article as a
supplement. Description: The American College of Physicians (ACP) developed this …
supplement. Description: The American College of Physicians (ACP) developed this …
Eleven-year multimorbidity burden among 637 255 people with and without type 2 diabetes: a population-based study using primary care and linked hospitalisation …
Objectives To compare the patterns of 18 physical and mental health comorbidities between
people with recently diagnosed type 2 diabetes (T2D) and people without diabetes and how …
people with recently diagnosed type 2 diabetes (T2D) and people without diabetes and how …
[PDF][PDF] Predictors and Consequences of Severe Hypoglycemia in Adults with Diabetes–A Systematic Review of the Evidence
HE Bloomfield, N Greer, D Newman, R MacDonald… - 2012 - hsrd.research.va.gov
Predictors and Consequences of Severe Hypoglycemia in Adults with Diabetes –A Systematic
Review of the Evidence Page 1 Evidence-based Synthesis Program Department of Veterans …
Review of the Evidence Page 1 Evidence-based Synthesis Program Department of Veterans …
Application of electronic medical record data for health outcomes research: a review of recent literature
J Lin, T Jiao, JE Biskupiak… - Expert review of …, 2013 - Taylor & Francis
Electronic medical records (EMRs) have become a common source of data for outcomes
research. This review discusses trends in EMR data use for outcomes research as well as …
research. This review discusses trends in EMR data use for outcomes research as well as …
Balancing risk and benefit with oral hypoglycemic drugs
OPR Hamnvik, GT McMahon - … Journal of Medicine: A Journal of …, 2009 - Wiley Online Library
Clinicians are faced with an expansive array of treatment choices when caring for patients
with type 2 diabetes. Because patient compliance may be affected when media …
with type 2 diabetes. Because patient compliance may be affected when media …
[PDF][PDF] Drug class review: newer diabetes medications, TZDs and combinations
D Jonas, E Van Scoyoc, K Gerrald, R Wines… - Oregon Health & …, 2011 - academia.edu
Drug Class Review Newer Diabetes Medications, TZDs, and Combinations Page 1 Drug Class
Review Newer Diabetes Medications, TZDs, and Combinations Final Original Report February …
Review Newer Diabetes Medications, TZDs, and Combinations Final Original Report February …
A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients
L Hakobyan, FM Haaijer-Ruskamp, D de Zeeuw… - Health and quality of life …, 2011 - Springer
Clinical drug trials are often conducted in selective patient populations, with relatively small
numbers of patients, and a short duration of follow-up. Observational studies are therefore …
numbers of patients, and a short duration of follow-up. Observational studies are therefore …
The relationship between patient-reported tolerability issues with oral antidiabetic agents and work productivity among patients having type 2 diabetes
M DiBonaventura, C Link, MF Pollack… - … of occupational and …, 2011 - journals.lww.com
Objective: To investigate the association between reported oral antidiabetic tolerability
issues and work productivity, activity impairment, and indirect costs. Methods: Data were …
issues and work productivity, activity impairment, and indirect costs. Methods: Data were …